CDAI and DAS28-CRP agreement in rheumatoid arthritis: a tertiary-care cross-sectional study with exploratory machine learning

Accurately evaluating disease activity in rheumatoid arthritis is crucial for guiding treatment decisions and monitoring patient outcomes. The Disease Activity Score based on 28 joints and C-reactive protein (DAS28-CRP) is widely used but requires laboratory testing and calculation, which can limit immediate use in resource-constrained settings. The Clinical Disease Activity Index (CDAI) offers a simpler alternative based entirely on clinical assessment. In this cross-sectional tertiary-care study, we examined same-visit agreement between CDAI and DAS28-CRP among 139 treated patients from Nepal and explored internally validated machine-learning (ML) models as a secondary exploratory analysis. CDAI distinguished remission/low from moderate/high DAS28-CRP activity with sensitivity of 88.1%, specificity of 97.2%, and ROC-AUC of 0.983. CDAI and DAS28-CRP were strongly correlated (Spearman \(\rho =0.955\) ; Pearson \(r=0.938\) ), and four-level disease-activity categories showed 71.9% observed agreement with substantial weighted agreement. Exploratory ML models showed high internal performance, but predictors overlapped substantially with DAS28-CRP, the sample was small, and these analyses should not be interpreted as evidence for routine clinical use. Discordant cases, particularly patients classified as remission/low activity by CDAI but moderate/high activity by DAS28-CRP, highlight the need for clinical judgment and laboratory assessment when indicated. These findings support CDAI as a practical assessment tool in this setting, while emphasizing that CDAI should complement rather than replace clinician assessment and that ML findings require external validation.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-20
DOI
https://doi.org/10.1038/s41598-026-79823-1
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CDAI and DAS28-CRP agreement in rheumatoid arthritis: a tertiary-care cross-sectional study with exploratory machine learning

Deepak Ghimire, Md Abdus Samad, Buddhi Paudyal, Kanshiram B. K. et al.
1 links
Scientific Reports
Rheumatoid Arthritis Research and Therapies
article

CDAI and DAS28-CRP agreement in rheumatoid arthritis: a tertiary-care cross-sectional study with exploratory machine learning

Deepak Ghimire, Md Abdus Samad, Buddhi Paudyal, Kanshiram B. K., Lucky Sharma, Santosh Ghimire, A. S. M. Sanwar Hosen
article en

Abstract

Accurately evaluating disease activity in rheumatoid arthritis is crucial for guiding treatment decisions and monitoring patient outcomes. The Disease Activity Score based on 28 joints and C-reactive protein (DAS28-CRP) is widely used but requires laboratory testing and calculation, which can limit immediate use in resource-constrained settings. The Clinical Disease Activity Index (CDAI) offers a simpler alternative based entirely on clinical assessment. In this cross-sectional tertiary-care study, we examined same-visit agreement between CDAI and DAS28-CRP among 139 treated patients from Nepal and explored internally validated machine-learning (ML) models as a secondary exploratory analysis. CDAI distinguished remission/low from moderate/high DAS28-CRP activity with sensitivity of 88.1%, specificity of 97.2%, and ROC-AUC of 0.983. CDAI and DAS28-CRP were strongly correlated (Spearman \(\rho =0.955\) ; Pearson \(r=0.938\) ), and four-level disease-activity categories showed 71.9% observed agreement with substantial weighted agreement. Exploratory ML models showed high internal performance, but predictors overlapped substantially with DAS28-CRP, the sample was small, and these analyses should not be interpreted as evidence for routine clinical use. Discordant cases, particularly patients classified as remission/low activity by CDAI but moderate/high activity by DAS28-CRP, highlight the need for clinical judgment and laboratory assessment when indicated. These findings support CDAI as a practical assessment tool in this setting, while emphasizing that CDAI should complement rather than replace clinician assessment and that ML findings require external validation.

Scientific Reports
Patan Academy of Health Sciences (NP), Korea Electronics Technology Institute (KR), Maharajgunj Medical Campus (NP), Yeungnam University (KR), Woosong University (KR)
Good health and well-being
Rheumatoid Arthritis Research and Therapies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon